跳至主要内容
临床试验/NCT03550040
NCT03550040终止不适用

3D Versus Robot Assisted Laparoscopic Prostatectomy. A Prospective Randomized Non-inferiority Study.

Tampere University Hospital1 个研究点 分布在 1 个国家目标入组 155 人开始时间: 2018年5月31日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
155
试验地点
1
主要终点
Urinary continence

研究概览

简要总结

A randomized, prospective study to compare the direct and indirect costs, functional and oncologic results of 3D laparoscopic and robot assisted radical prostatectomy procedures.

详细描述

The direct and indirect costs, functional and oncologic results of robot assisted radical prostatectomy (RALP) are compared to those of 3D laparoscopic radical prostatectomy. The hypothesis of the study is that the functional and oncologic results of the two operative methods are equal, but the direct costs of RAPL are significantly higher. A randomized, prospective non-inferiority study will will enroll 280 patients randomized 1:1 to both operative approaches to test this hypothesis. The primary functional outcome measure is the proportion of patients with complete urinary continence (no protective pad use) at 12 months post operatively. Secondary functional outcome measure is the preservation erectile function at 12 months post operatively. Oncologic outcome measures are the proportion of patients with undetectable post operative prostate specific antigen levels and positive surgical margins at pathological examination. The direct and indirect costs of both operative approaches are recorded.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
34 Years 至 74 Years(Adult, Older Adult)
性别
Male
接受健康志愿者
否

入选标准

  • •Localized prostate cancer undergoing radical prostatectomy
  • •Patient has to understand and be able to write and read Finnish language
  • •No prior head injury, dementia or Parkinson's disease
  • •No concomitant malignant illness
  • •Life expectancy of at least 10 years
  • •35-74 years of age

排除标准

  • •Locally advanced prostate cancer (T4)
  • •Suspicion or documented metastases (M1)
  • •Serum PSA > 20 ng/ml
  • •Prior laparoscopic hernia surgery employing non resorbable mesh
  • •Prior pelvic irradiation or major surgery
  • •Prior malignant disease within prior 5 years excluding skin cancer (non-melanoma).

研究组 & 干预措施

Robot assisted prostatectomy.

Active Comparator

Intervention: radical prostatectomy

干预措施: Radical prostatectomy (Procedure)

3D laparoscopic prostatectomy

Experimental

Intervention: radical prostatectomy

干预措施: Radical prostatectomy (Procedure)

结局指标

主要结局

Urinary continence

时间窗: 12 months

Expanded Prostate Cancer Index Composite (EPIC) Short Form (EPIC-26), urinary domain score is used to assess the return of continence post operatively. The percentage of patients with no protective pad use at 12 months post operatively is the main outcome measure.

次要结局

  • Prostate specific antigen(12 months)
  • Evaluation of surgical margins at pathologic examination.(up to 12 months)
  • Erectile function(12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Antti Kaipia

Chief physician, department of urology

Tampere University Hospital

研究点 (1)

Loading locations...

相似试验

3D Versus Robot Assisted Laparoscopic Prostatectomy. | 临床试验